Induction of hepatic metallothionein by intraperitoneal metal injection: an associated inflammatory response.
The nature of hepatic metallothionein (MT) induction by several metals and its relationship to an inflammatory response was studied in chicks. Intraperitoneal (ip) injection of chromium (Cr), managanese, and iron (Fe) caused a much greater increase in hepatic MT (10.2-, 9.0-, and 6.8-fold) compared with cobalt and nickel (2.5- and 2.9-fold); thus not all transition metals are effective. Cr3+ caused markedly greater hepatic MT accumulation than Cr6+, suggesting that the ionic nature of the metal is an important factor. Small organic complexes of Fe (ferrous gluconate or lactate, 6.2-fold) caused significantly greater accumulation of hepatic MT than ferric dextran (1.4-fold), a large organic aggregate. In vitro data from chick hepatocytes and/or fibroblasts clearly indicated that Fe does not effect the induction of MT directly. The role of inflammation, as measured by recruitment of peritoneal exudate cells (PEC), was examined. Endotoxin (LPS), Sephadex (S), and Fe elicited significant elevations in PEC number at 24 h posttreatment (S), and Fe elicited significant elevations in PEC number at 24 h posttreatment (S = Fe greater than LPS much greater than control). The percentage of heterophils but not macrophages was significantly correlated with the accumulation and induction of hepatic MT. In a similar experiment with Cr, we demonstrated that Cr3+ but not Cr6+ stimulated MT messenger RNA accumulation and concomitant hetereophil infiltration at 3 h after injection. Our results indicate that the induction of hepatic MT by the parenteral administration of a number of metals is dependent on the chemical nature of the metal and is associated with an inflammatory response.
Fleet
J C
JC
Department of Poultry and Avian Science, Cornell University, Ithaca, New York 14853.
Golemboski
K A
KA
Dietert
R R
RR
Andrews
G K
GK
McCormick
C C
CC
D000818:Animals; D002478:Cells, Cultured; D002642:Chick Embryo; D002645:Chickens; D002712:Chlorides; D002857:Chromium / Q000633:toxicity; D017608:Chromium Compounds; D003035:Cobalt / Q000633:toxicity; D005290:Ferric Compounds / Q000633:toxicity; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D007249:Inflammation; D007274:Injections, Intraperitoneal; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D008297:Male; D017895:Manganese Compounds; D020149:Manganese Poisoning; D008668:Metallothionein / Q000096:biosynthesis*; D008670:Metals / Q000008:administration & dosage / Q000633:toxicity*; D009532:Nickel / Q000633:toxicity
D002712:Chlorides; D017608:Chromium Compounds; D005290:Ferric Compounds; D017895:Manganese Compounds; D008670:Metals; D002857:Chromium; D003035:Cobalt; C022838:nickel chloride; D009532:Nickel; D008668:Metallothionein; C017133:chromous chloride; C018021:cobaltous chloride; C025340:manganese chloride; C024555:ferric chloride